Ellevest, Inc. Kura Oncology, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$10.71 - $14.6 $10 - $14	1 New	1 $0
Q2 2022 Jul 18, 2022	SELL	$10.71 - $18.33 $1,317 - $2,254	-123 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$15.42 - $21.72 $1,819 - $2,562	118 Added 2360.0%	123 $2,000
Q1 2021 May 03, 2021	SELL	$24.75 - $39.14 $668 - $1,056	-27 Reduced 84.38%	5 $0
Q4 2020 Feb 04, 2021	BUY	$29.0 - $41.62 $783 - $1,123	27 Added 540.0%	32 $1,000
Q3 2020 Oct 26, 2020	BUY	$16.3 - $30.64 $81 - $153	5 New	5 $0

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $490M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.